pteridines has been researched along with Cerebral Primitive Neuroectodermal Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, C | 1 |
| Schubert, NA | 1 |
| Brabetz, S | 1 |
| Mack, N | 1 |
| Schwalm, B | 1 |
| Chan, JA | 1 |
| Selt, F | 1 |
| Herold-Mende, C | 1 |
| Witt, O | 1 |
| Milde, T | 1 |
| Pfister, SM | 1 |
| Korshunov, A | 1 |
| Kool, M | 1 |
1 other study available for pteridines and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Ch | 2017 |